The Effect of Metabolic Syndrome on the Success and Complications of Percutaneous Nephrolitotomy

dc.contributor.authorNalbant, Ismail
dc.contributor.authorDede, Onur
dc.contributor.authorSener, Nevzat Can
dc.contributor.authorOzturk, Ufuk
dc.contributor.authorYesil, Suleyman
dc.contributor.authorKarakoyunlu, A. Nihat
dc.contributor.authorImamoglu, M. Abdurrahim
dc.date.accessioned2024-04-24T17:08:02Z
dc.date.available2024-04-24T17:08:02Z
dc.date.issued2015
dc.departmentDicle Üniversitesien_US
dc.description.abstractBackground: The aim of this study was to investigate the effect of Metabolic syndrome (MetS) on the success and complications of percutaneous nephrolithotomy (PNL). Methods: Two hundred ten patients who had undergone PNL for kidney stones in our clinic between May 2012 and May 2014 were retrospectively analyzed. The patients were divided into two groups based on whether they had diagnostic criteria for MetS. All patients had lower pole kidney stones between 15 and 20mm. Complication rates between groups were evaluated using a modified Clavien grading system. Results: Group1 was a standard PNL group and group 2 consisted of patients with MetS. Mean stone size was 293.25102.4mm(2) for group 1 and 301.10 +/- 169.5mm(2) for group 2 (p<0.05). Mean hospitalization days, fluoroscopy duration, and mean hematocrit loss were significantly higher in group 2. Mean operative time and need for blood transfusions were higher in group 2 but statistically insignificant. One hundred twenty five patients in group 1 (96.1%) and 72 patients in group 2 (90%) obtained stone-free state. Conclusions: Our study results reveal an increase in complications and morbidity for patients with MetS during PNL.en_US
dc.identifier.doi10.1089/met.2015.0041
dc.identifier.endpage392en_US
dc.identifier.issn1540-4196
dc.identifier.issn1557-8518
dc.identifier.issue9en_US
dc.identifier.pmid26313322
dc.identifier.scopus2-s2.0-84946708971
dc.identifier.scopusqualityQ2
dc.identifier.startpage389en_US
dc.identifier.urihttps://doi.org/10.1089/met.2015.0041
dc.identifier.urihttps://hdl.handle.net/11468/17171
dc.identifier.volume13en_US
dc.identifier.wosWOS:000363888500004
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherMary Ann Liebert, Incen_US
dc.relation.ispartofMetabolic Syndrome and Related Disorders
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleThe Effect of Metabolic Syndrome on the Success and Complications of Percutaneous Nephrolitotomyen_US
dc.titleThe Effect of Metabolic Syndrome on the Success and Complications of Percutaneous Nephrolitotomy
dc.typeArticleen_US

Dosyalar